IGF1R and neoplasm: Then again, as no association between IGF1R expression and survival was found in the present study and IR expressing CRCs were found to have an even improved survival [4], it remains questionable, if even an IGF1R / IR-A-targeted dual therapy is suitable for this tumor type.